Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cell Death Discovery is Scopus-indexed (Q1, CiteScore 13.2), WoS SCIE, DOAJ. Published by Nature Publishing Group.
Checked against the index lists dated .
ISSN 2058-7716Verify ISSN ↗
Publisher: Nature Publishing Group
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cellular and Molecular Neuroscience | 11 / 102 | 89th | Q1 |
| Immunology | 30 / 243 | 87th | Q1 |
| Cancer Research | 29 / 233 | 87th | Q1 |
| Cell Biology | 38 / 289 | 87th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 13.2.
Cell Death Discovery is Q1 in Cellular and Molecular Neuroscience (rank 11 of 102), Q1 in Immunology (rank 30 of 243) and Q1 in Cancer Research (rank 29 of 233), by CiteScore 2025. It is ranked in 4 subject areas in all.
Cell Death Discovery is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.2, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.668, quartile Q1, with an H-index of 86.
The publisher lists an article processing charge of about US$2,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cell Death Discovery is published by Nature Publishing Group. Its ISSN is 2058-7716.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cell Death Discovery has an h-index of 108 and a 2-year mean of 10.95 citations per paper (OpenAlex). Its Scopus CiteScore is 13.2, quartile Q1. On 2-year citations it ranks #6 of 102 Scopus journals in Cellular and Molecular Neuroscience.
Cell Death Discovery published 622 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from China (54.5%), United States (10.4%) and Italy (5.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 10 retracted papers are recorded (2.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.